Literature DB >> 21704216

Serum antimüllerian hormone in healthy premenopausal women.

Christiana M Shaw1, Frank Z Stanczyk, Brian L Egleston, L L Kahle, Cynthia S Spittle, Andrew K Godwin, Louise A Brinton, Joanne F Dorgan.   

Abstract

Antimüllerian hormone (AMH) is extensively studied in ovarian aging and pathology; however, little is known about correlates in healthy premenopausal women. We found that AMH levels are strongly inversely associated with age and differed significantly between oral contraceptive pill users and nonusers, whereas no significant associations were seen between AMH and other clinical, behavioral, and anthropometric characteristics and laboratory variables, making it an attractive hormone for clinical applications.
Copyright © 2011 American Society for Reproductive Medicine. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21704216      PMCID： PMC3163405          DOI： 10.1016/j.fertnstert.2011.05.051

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  29 in total

1.  Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation.

Authors:  Antonio La Marca; Stefania Malmusi; Simone Giulini; Leo Fischer Tamaro; Raoul Orvieto; Paola Levratti; Annibale Volpe
Journal:  Hum Reprod       Date:  2004-09-30       Impact factor: 6.918

2.  Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.

Authors:  Wouter J K Hehenkamp; Caspar W N Looman; Axel P N Themmen; Frank H de Jong; E R Te Velde; Frank J M Broekmans
Journal:  J Clin Endocrinol Metab       Date:  2006-06-27       Impact factor: 5.958

3.  Editorial: Anti-Müllerian hormone: Cinderella finds new admirers.

Authors:  Ahmed Al-Qahtani; Nigel Patrick Groome
Journal:  J Clin Endocrinol Metab       Date:  2006-10       Impact factor: 5.958

Review 4.  Anti-Müllerian hormone: clinical insights into a promising biomarker of ovarian follicular status.

Authors:  Estelle Feyereisen; Daniel H Méndez Lozano; Joëlle Taieb; Laetitia Hesters; René Frydman; Renato Fanchin
Journal:  Reprod Biomed Online       Date:  2006-06       Impact factor: 3.828

5.  Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.

Authors:  Terhi Piltonen; Laure Morin-Papunen; Riitta Koivunen; Antti Perheentupa; Aimo Ruokonen; Juha S Tapanainen
Journal:  Hum Reprod       Date:  2005-03-31       Impact factor: 6.918

6.  Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study.

Authors:  Ilse A J van Rooij; Frank J M Broekmans; Gabrielle J Scheffer; Caspar W N Looman; J Dik F Habbema; Frank H de Jong; Bart J C M Fauser; Axel P N Themmen; Egbert R te Velde
Journal:  Fertil Steril       Date:  2005-04       Impact factor: 7.329

7.  Ovarian and adrenal steroid production: regulatory role of LH/HCG.

Authors:  T Piltonen; R Koivunen; L Morin-Papunen; A Ruokonen; I T Huhtaniemi; J S Tapanainen
Journal:  Hum Reprod       Date:  2002-03       Impact factor: 6.918

8.  Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

Authors:  Pascal Pigny; Emilie Merlen; Yann Robert; Christine Cortet-Rudelli; Christine Decanter; Sophie Jonard; Didier Dewailly
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

9.  Use of ovarian reserve tests for the prediction of ongoing pregnancy in couples with unexplained or mild male infertility.

Authors:  Ilse A J van Rooij; Frank J M Broekmans; Claudine C Hunault; Gabriëlle J Scheffer; Marinus J C Eijkemans; Frank H de Jong; Axel P N Themmen; Egbert R te Velde
Journal:  Reprod Biomed Online       Date:  2006-02       Impact factor: 3.828

10.  Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition.

Authors:  Ilse A J van Rooij; Isolde den Tonkelaar; Frank J M Broekmans; Caspar W N Looman; Gabrielle J Scheffer; Frank H de Jong; Axel P N Themmen; Egbert R te Velde
Journal:  Menopause       Date:  2004 Nov-Dec       Impact factor: 2.953
View more
  23 in total

1.  Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial.

Authors:  Austin D Findley; Matthew T Siedhoff; Kumari A Hobbs; John F Steege; Erin T Carey; Christina A McCall; Anne Z Steiner
Journal:  Fertil Steril       Date:  2013-08-29       Impact factor: 7.329

2.  Anti-Müllerian Hormone Levels and Urinary Cortisol in Women With Chronic Abdominal Pain.

Authors:  Theresa M Hardy; Donna O McCarthy; Nicolaas H Fourie; Wendy A Henderson
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2016-09-14

3.  Obesity adversely affects serum anti-müllerian hormone (AMH) levels in Caucasian women.

Authors:  Vicky Moy; Sangita Jindal; Harry Lieman; Erkan Buyuk
Journal:  J Assist Reprod Genet       Date:  2015-07-21       Impact factor: 3.412

4.  Antimüllerian hormone in relation to tobacco and marijuana use and sources of indoor heating/cooking.

Authors:  Alexandra J White; Dale P Sandler; Aimee A D'Aloisio; Frank Stanczyk; Kristina W Whitworth; Donna D Baird; Hazel B Nichols
Journal:  Fertil Steril       Date:  2016-05-27       Impact factor: 7.329

5.  Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women.

Authors:  Leah Hawkins Bressler; Lia A Bernardi; Peter John D De Chavez; Donna D Baird; Mercedes R Carnethon; Erica E Marsh
Journal:  Am J Obstet Gynecol       Date:  2016-07-11       Impact factor: 8.661

6.  Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.

Authors:  Annie A Guedikian; Alexandria Y Lee; Tristan R Grogan; David H Abbott; Karla Largaespada; Gregorio D Chazenbalk; Daniel A Dumesic
Journal:  Fertil Steril       Date:  2018-02-07       Impact factor: 7.329

7.  Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone, and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank.

Authors:  Sarah R Irvin; Elisabete Weiderpass; Frank Z Stanczyk; Louise A Brinton; Britton Trabert; Hilde Langseth; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-01-13       Impact factor: 4.254

8.  Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women.

Authors:  Seungyoun Jung; Naomi Allen; Alan A Arslan; Laura Baglietto; Louise A Brinton; Brian L Egleston; Roni Falk; Renée T Fortner; Kathy J Helzlsouer; Annika Idahl; Rudolph Kaaks; Eva Lundin; Melissa Merritt; Charlotte Onland-Moret; Sabina Rinaldi; María-José Sánchez; Sabina Sieri; Helena Schock; Xiao-Ou Shu; Patrick M Sluss; Paul N Staats; Ruth C Travis; Anne Tjønneland; Antonia Trichopoulou; Shelley Tworoger; Kala Visvanathan; Vittorio Krogh; Elisabete Weiderpass; Anne Zeleniuch-Jacquotte; Wei Zheng; Joanne F Dorgan
Journal:  Fertil Steril       Date:  2017-04       Impact factor: 7.329

9.  Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception.

Authors:  Lauren N C Johnson; Mary D Sammel; Katherine E Dillon; Lara Lechtenberg; Allison Schanne; Clarisa R Gracia
Journal:  Fertil Steril       Date:  2014-06-14       Impact factor: 7.329

10.  Early Life Body Fatness, Serum Anti-Müllerian Hormone, and Breast Density in Young Adult Women.

Authors:  Kimberly A Bertrand; Heather J Baer; E John Orav; Catherine Klifa; Ajay Kumar; Nola M Hylton; Erin S LeBlanc; Linda G Snetselaar; Linda Van Horn; Joanne F Dorgan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-09       Impact factor: 4.254
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.